The IBC is charged with the responsibility for review, approval and surveillance of all research protocols at the University of Chicago involving the use of biohazardous materials including recombinant DNA, agents infectious to humans, animals or plants, and other genetically altered organisms and agents.
For purposes of the Institutional Biosafety Committee, biohazards are defined as potentially infectious agents, organisms or materials, biological toxins, organisms containing recombinant DNA and other genetically altered organisms and agents. Using these materials in laboratory or clinical settings requires the prior review and approval of the Institutional Biosafety Committee, and may require the review of the Institutional Animal Care and Use Committee or the Institutional Review Board (Humans).
Both IBCs have regularly scheduled monthly meetings. Additional special meetings are called as necessary. These meetings are not open to anyone other than members of the IBC, staff of the IBC Office and Office of Biosafety or individuals who have received permission from the IBC Chair.
The University of Chicago lacks facilities requiring BSL4 or ABSL4 containment. Therefore, research requiring such containment cannot be performed at the University of Chicago. Investigators wishing to perform research requiring BL3 or ABSL3 containment should consult with the University of Chicago Office of Biological Safety prior to grant preparation or IBC protocol submission.